5ADDINGTON A M, GALLO J J, FORD D E, el al. Epidemiol- ogy of unexplained fatigue and major depression in the com- munity: the Baltimore ECA follow-up, 1981-1994 [ J ]. Psychol Med,2001,31 : 1037-1044.
6Tubergen A V, Ramiro S, Heijde D, et al. Development of new syndesmophytes and bridges in ankkylosing spondtlitis and their predic-tors : a longitudinal study [ J ] - Ann Rheum Dis, 2012,71(4):518-523.
7Goie T H, Steven M M, van der Linden S M, et al. E- valuation of diagnostic criteria for ankylosing 3Dondvlitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis [ J ]. Br J Rheun- matol, 1985,24 ( 3 ) : 242-249.
8Garrett S, Jenkinson T, Kennedy L G, et al. A new ap- proach to defining disease status in ankylosing spondyli- tis: the bath ankylosing spondylitis disease activity index [ J]. J Rheumatol, 1994,21 (12) :2286-2291.
9Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index[ J]. J Rheumatol, 1994,21 ( 12 ) :2281-2285.
10Jenkinson T R, Mallorie P A, Whitelock H C, et al. De- fining spinal mobility in ankylosing spondylitis(AS). The Bath AS Metrology Index [ J ]. J Rheumatol, 1994, 21 (9) :1694-1698.
